Combined Plasma DHA-Containing Phosphatidylcholine PCaa C38:6 and Tetradecanoyl-Carnitine as an Early Biomarker for Assessing the Mortality Risk among Sarcopenic Patients.

"Conflicts of Interest The authors declare no conflicts of interest."

"This research was funded by Chang Gung Memorial Hospital (grant number: BMRP819, BMRP564, CMRPD1L0161, CMRPD1L0162, CMRPD1M0351, CMRPD1J0263, CMRPD1M0341, CLRPG3K0023, CMRPD1M0352, CMRPD1N0151, CMRPD1M0342 and CMRPD1N0071), National Science and Technology Council (NSTC) (grant number: 110-2320-B-182-017-MY3, 111-2320-B-182-011 and 112-2320-B-182-020-MY3), and Ministry of Education in Taiwan (MOE) (EMRPD1K0441, EMRPD1K0481, and EMRPD1L0421). This work was also supported by the Research Center for Emerging Viral Infections from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan and the National Science and Technology Council (NSTC), Taiwan (MOST 111-2634-F-182-001)."